Table of Contents
Bone Marrow Research
Volume 2012, Article ID 485160, 9 pages
http://dx.doi.org/10.1155/2012/485160
Review Article

The Role of HLA in Cord Blood Transplantation

Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens (BRFAA), 4 Soranou Efessiou Street, 115 27 Athens, Greece

Received 23 July 2012; Accepted 12 September 2012

Academic Editor: Andrzej Lange

Copyright © 2012 Catherine Stavropoulos-Giokas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. D. Thomas, C. D. Buckner, M. Banaji et al., “One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogenic marrow transplantation,” Blood, vol. 49, no. 4, pp. 511–533, 1977. View at Google Scholar · View at Scopus
  2. K. G. Blume, E. Beutler, K. J. Bross et al., “Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia,” The New England Journal of Medicine, vol. 302, pp. 1041–1046, 1980. View at Publisher · View at Google Scholar
  3. J. E. Wagner and E. Gluckman, “Umbilical cord blood transplantation: the first 20 years,” Seminars in Hematology, vol. 47, no. 1, pp. 3–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Barrett, E. Gluckman, R. Handgretinger, and A. Madrigal, “Point-counterpoint: haploidentical family donors versus cord blood transplantation,” Biology of Blood and Marrow Transplantation, vol. 17, supplement 1, pp. S89–S93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. K. Ballen, J. Hicks, B. Dharan et al., “Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors,” Transfusion, vol. 42, no. 10, pp. 1279–1284, 2002. View at Google Scholar · View at Scopus
  6. R. Handgretinger, T. Klingebiel, P. Lang et al., “Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children,” Bone Marrow Transplantation, vol. 27, no. 8, pp. 777–783, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Lee, J. Klein, M. Haagenson et al., “High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation,” Blood, vol. 110, no. 13, pp. 4576–4583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Kamani, S. Spellman, C. K. Hurley et al., “State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants,” Biology of Blood and Marrow Transplantation, vol. 14, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Gluckman and V. Rocha, “Cord blood transplantation:state of the art,” Haematologica, vol. 94, no. 4, pp. 451–454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Gutman, S. R. Riddell, S. McGoldrick, and C. Delaney, “Double unit cord blood transplantation: who wins-and why do we care?” Chimerism, vol. 1, no. 1, pp. 21–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Klein and A. Sato, “Advances in immunology: the HLA system,” The New England Journal of Medicine, vol. 343, no. 11, pp. 782–786, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Trowsdale, “HLA genomics in the third millennium,” Current Opinion in Immunology, vol. 17, no. 5, pp. 498–504, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. I. Lechler, G. Lombardi, J. R. Batchelor, N. Reinsmoen, and F. H. Bach, “The molecular basis of alloreactivity,” Immunology Today, vol. 11, no. 3, pp. 83–88, 1990. View at Google Scholar · View at Scopus
  14. C. K. Hurley, M. Fernandez-Vina, W. H. Hildebrand et al., “A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient Pairs,” Human Immunology, vol. 68, no. 1, pp. 30–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. G. Marsh, “Nomenclature for factors of the HLA system,” International Journal of Immunogenetics, vol. 39, no. 4, pp. 370–372, 2012. View at Publisher · View at Google Scholar
  16. J. M. Tiercy, J. Villard, and E. Roosnek, “Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays,” Transplant Immunology, vol. 10, no. 2-3, pp. 215–221, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Little, S. G. E. Marsh, and J. A. Madrigal, “Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection,” Current Opinion in Hematology, vol. 5, no. 6, pp. 419–428, 1998. View at Google Scholar · View at Scopus
  18. P. P. J. Dunn, “Human leucocyte antigen typing: techniques and technology, a critical appraisal,” International Journal of Immunogenetics, vol. 38, no. 6, pp. 463–473, 2011. View at Publisher · View at Google Scholar
  19. K. K. Ballen, “New trends in umbilical cord blood transplantation,” Blood, vol. 105, no. 10, pp. 3786–3792, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. E. Wagner, N. A. Kernan, M. Steinbuch, H. E. Broxmeyer, and E. Gluckman, “Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease,” The Lancet, vol. 346, no. 8969, pp. 214–219, 1995. View at Google Scholar · View at Scopus
  21. J. Kurtzberg, M. Laughlin, M. L. Graham et al., “Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients,” The New England Journal of Medicine, vol. 335, no. 3, pp. 157–166, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Rocha, G. Sanz, and E. Gluckman, “Umbilical cord blood transplantation,” Current Opinion in Hematology, vol. 11, no. 6, pp. 375–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Rocha, J. E. Wagner, K. A. Sobocinski et al., “Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling,” The New England Journal of Medicine, vol. 342, no. 25, pp. 1846–1854, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Cohen and A. Nagler, “Umbilical cord blood transplantation—how, when and for whom?” Blood Reviews, vol. 18, no. 3, pp. 167–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Locatelli, V. Rocha, W. Reed et al., “Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease,” Blood, vol. 101, no. 6, pp. 2137–2143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Reed, R. Smith, F. Dekovic et al., “Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease,” Blood, vol. 101, no. 1, pp. 351–357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Stavropoulos-Giokas and A. C. Papassavas, “Cord blood banking and transplantation: a promising reality,” HAEMA, vol. 9, no. 6, pp. 736–756, 2006. View at Google Scholar · View at Scopus
  28. S. S. Grewal, J. P. Kahn, M. L. MacMillan, N. K. C. Ramsay, and J. E. Wagner, “Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis,” Blood, vol. 103, no. 3, pp. 1147–1151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Basille, R. Frydman, A. E. Aly et al., “Preimplantation genetic diagnosis: state of the art,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 145, no. 1, pp. 9–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Goussetis, E. Petrakou, M. Theodosaki et al., “Directed sibling donor cord blood banking for children with β-thalassemia major in Greece: usage rate and outcome of transplantation for HLA-matched units,” Blood Cells, Molecules, and Diseases, vol. 44, no. 2, pp. 107–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Kurtzberg, V. K. Prasad, S. L. Carter et al., “Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies,” Blood, vol. 112, no. 10, pp. 4318–4327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. N. R. Kamani, M. C. Walters, S. Carter et al., “Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the blood and marrow transplant clinical trials network (BMT CTN),” Biology of Blood and Marrow Transplantation, vol. 18, no. 8, pp. 1265–1272, 2012. View at Publisher · View at Google Scholar
  33. W. Reed, M. Walters, and B. H. Lubin, “Collection of sibling donor cord blood for children with thalassemia,” Journal of Pediatric Hematology/Oncology, vol. 22, no. 6, pp. 602–604, 2000. View at Google Scholar · View at Scopus
  34. T. H. Jaing, I. J. Hung, C. P. Yang, S. H. Chen, C. F. Sun, and R. Chow, “Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with β-thalassemia major,” Biology of Blood and Marrow Transplantation, vol. 11, no. 5, pp. 349–353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Rubinstein, C. Carrier, A. Scaradavou et al., “Outcomes among 562 recipients of placental-blood transplants from unrelated donors,” The New England Journal of Medicine, vol. 339, no. 22, pp. 1565–1577, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Yoshimi, S. Kojima, S. Taniguchi et al., “Unrelated cord blood transplantation for severe aplastic anemia,” Biology of Blood and Marrow Transplantation, vol. 14, no. 9, pp. 1057–1063, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. W. Chan, L. McDonald, D. Lim, M. S. Grimley, G. Grayson, and D. A. Wall, “Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia,” Bone Marrow Transplantation, vol. 42, no. 9, pp. 589–595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Childs, “Combined CB and Haploidentical CD34+ cell transplantation improves transplant outcome for patients with treatment-refractory severe aplastic anemia,” in Proceedings of the 10th International Cord Blood Symposium, San Francisco, Calif, USA, 2012.
  39. J. F. Fernandes, V. Rocha, M. Labopin et al., “Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?” Blood, vol. 119, pp. 2949–2955, 2012. View at Publisher · View at Google Scholar
  40. S. L. Staba, M. L. Escolar, M. Poe et al., “Cord-blood transplants from unrelated donors in patients with hurler's syndrome,” The New England Journal of Medicine, vol. 350, no. 19, pp. 1960–1969, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Sun, J. Allison, C. McLaughlin et al., “Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders,” Transfusion, vol. 50, no. 9, pp. 1980–1987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Eapen, V. Rocha, G. Sanz et al., “Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis,” The Lancet Oncology, vol. 11, no. 7, pp. 653–660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Laughlin, J. Barker, B. Bambach et al., “Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors,” The New England Journal of Medicine, vol. 344, no. 24, pp. 1815–1822, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. G. D. Long, M. Laughlin, B. Madan et al., “Unrelated umbilical cord blood transplantation in adult patients,” Biology of Blood and Marrow Transplantation, vol. 9, no. 12, pp. 772–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. G. F. Sanz, S. Saavedra, D. Flanelles et al., “Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies,” Blood, vol. 98, no. 8, pp. 2332–2338, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. M. de Lima, M. Fernandez-Vina, and E. J. Shpall, “HLA matching of CB: it's complicated,” Blood, vol. 118, no. 14, pp. 3761–3762, 2011. View at Publisher · View at Google Scholar
  47. C. E. Stevens, C. Carrier, C. Carpenter, D. Sung, and A. Scaradavou, “HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection,” Blood, vol. 118, no. 14, pp. 3969–3978, 2011. View at Publisher · View at Google Scholar
  48. A. Nagler, C. Brautbar, S. Slavin, and A. Bishara, “Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity,” Bone Marrow Transplantation, vol. 18, no. 5, pp. 891–897, 1996. View at Google Scholar · View at Scopus
  49. M. Eapen, J. P. Klein, G. F. Sanz et al., “Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis,” The Lancet Oncology, vol. 12, no. 13, pp. 1214–1221, 2011. View at Publisher · View at Google Scholar
  50. N. Flomenberg, L. A. Baxter-Lowe, D. Confer et al., “Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome,” Blood, vol. 104, no. 7, pp. 1923–1930, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. E. W. Petersdorf, C. Anasetti, P. J. Martin et al., “Limits of HLA mismatching in unrelated hematopoietic cell transplantation,” Blood, vol. 104, no. 9, pp. 2976–2980, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. R. A. Bray, C. K. Hurley, N. R. Kamani et al., “National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants,” Biology of Blood and Marrow Transplantation, vol. 14, supplement 9, pp. 45–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. S. R. Spellman, M. Eapen, B. R. Logan et al., “A perspective on the selection of unrelated donors and cord blood units for transplantation,” Blood, vol. 120, no. 2, pp. 259–265, 2012. View at Publisher · View at Google Scholar
  54. J. J. Van Rood, C. E. Stevens, J. Smits, C. Carrier, C. Carpenter, and A. Scaradavou, “Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 19952–19957, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Rocha, D. Purtill, M. Zhang et al., “Impact of matching at non-inherited maternal antigenson outcomes after 5/6 or 4/6 HLA mismatched unrelated cord blood transplantation for malignant haematological disease. A matched pair analysis on behalf of Eurocord, Netcord, NMDP, CIBMTR,” Bone Marrow Transplantation, vol. 46, supplement 1, p. S2, 2011, Abstract O115. View at Google Scholar
  56. J. Kanda, T. Ichinohe, K. Matsuo et al., “Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies,” Transfusion, vol. 49, no. 4, pp. 624–635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Blin, R. Traineau, S. Houssin et al., “Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source,” Biology of Blood and Marrow Transplantation, vol. 16, no. 9, pp. 1315–1323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Spellman, R. Bray, S. Rosen-Bronson et al., “The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure,” Blood, vol. 115, no. 13, pp. 2704–2708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Takanashi, Y. Atsuta, K. Fujiwara et al., “The impact of anti-HLA antibodies on unrelated cord blood transplantations,” Blood, vol. 116, no. 15, pp. 2839–2846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Cutler, H. T. Kim, L. Sun et al., “Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation,” Blood, vol. 118, no. 25, pp. 6691–6697, 2011. View at Publisher · View at Google Scholar
  61. M. A. Fernandez-Vina, M. de Lima, and S. O. Ciurea, “Humoral HLA sensitization matters in CBT outcome,” Blood, vol. 118, no. 25, pp. 6482–6484, 2011. View at Publisher · View at Google Scholar
  62. C. G. Brunstein, J. A. Gutman, D. J. Weisdorf et al., “Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood,” Blood, vol. 116, no. 22, pp. 4693–4699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Avery, W. Shi, M. Lubin et al., “Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts,” Blood, vol. 117, no. 12, pp. 3277–3285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Scaradavou, K. M. Smith, R. Hawke et al., “Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation,” Biology of Blood and Marrow Transplantation, vol. 16, no. 4, pp. 500–508, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Querol, S. G. Gomez, A. Pagliuca, M. Torrabadella, and J. A. Madrigal, “Quality rather than quantity: the cord blood bank dilemma,” Bone Marrow Transplantation, vol. 45, no. 6, pp. 970–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Delaney, C. S. Cutler, R. L. Haspel et al., “High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults,” Transfusion, vol. 49, no. 5, pp. 995–1002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. J. N. Barker, A. Scaradavou, and C. E. Stevens, “Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies,” Blood, vol. 115, no. 9, pp. 1843–1849, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. C. G. Brunstein, E. J. Fuchs, S. L. Carter et al., “Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts,” Blood, vol. 118, no. 2, pp. 282–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Gluckman, A. Ruggeri, F. Volt, R. Cunha, K. Boudjedir, and V. Rocha, “Milestones in umbilical cord blood transplantation,” British Journal of Haematology, vol. 154, no. 4, pp. 441–447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Gluckman, Choice of Donor According to HLA Typing and Stem Cell Source, Heamatopoietic Stem Cell Transplantation, chapter 6, The EBMT Handbook, 6th edition, 2012.
  71. C. Mueller and S. Querol, Bone Marrow Donor Registries and Cord Blood Banks, Heamatopoietic Stem Cell Transplantation, chapter 6, The EBMT Handbook, 6th edition, 2012.
  72. NetCord and the Foundation for the Accreditation of Cellular Therapy (FACT), Ed., NetCord-FACT International Standards For Cord Blood Collection, Processing, and Release For Administration, 4th edition.
  73. C. Anasetti, F. Aversa, and C. G. Brunstein, “Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation?” Biology of Blood and Marrow Transplantation, vol. 18, supplement 1, pp. S161–S165, 2012. View at Publisher · View at Google Scholar
  74. J. Kuball, “Towards the next generation of transplantation: HIV positive patients,” in Proceedings of the 10th International Cord Blood Symposium, San Francisco, Calif, USA, 2012.
  75. L. D. Petz, “Cord Blood Transplants with Homozygous CCR5-Delta 32 Units as a means of providing possible cure of HIV infection,” in Proceedings of the 10th International Cord Blood Symposium, San Francisco, Calif, USA, 2012.
  76. K. Le Blanc, I. Rasmusson, B. Sundberg et al., “Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells,” The Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. V. Tisato, K. Naresh, J. Girdlestone, C. Navarrete, and F. Dazzi, “Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease,” Leukemia, vol. 21, no. 9, pp. 1992–1999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Giorgetti, N. Montserrat, T. Aasen et al., “Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2,” Cell Stem Cell, vol. 5, no. 4, pp. 353–357, 2009. View at Publisher · View at Google Scholar · View at Scopus